# Oncospace, Inc.: Form D filings

Oncospace, Inc., a biotechnology company in Baltimore, MD, filed 2 Form D notices with the SEC in 2019. The latest, on May 15, 2019, reports $900,000 sold of a $1.5 million offering to 11 investors.

Find out what Oncospace, Inc. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.

- [Watch for new raises](https://specstream.ai/workspace/ask?q=Tell%20me%20when%20Oncospace%2C%20Inc.%20files%20a%20new%20Form%20D%20or%20reports%20more%20money%20sold%2C%20with%20the%20filing&src=data-formd&kind=alert&entity=Oncospace%2C%20Inc.&page=%2Fdata%2Fform-d%2Fcompany%2Foncospace-inc-1773640)
- [Get founders and investors](https://specstream.ai/workspace/ask?q=For%20Oncospace%2C%20Inc.%2C%20find%20what%20the%20company%20does%2C%20its%20website%2C%20the%20founders%20and%20executives%20with%20their%20LinkedIn%20and%20work%20email%2C%20its%20investors%20and%20every%20funding%20round%20with%20the%20amounts%2C%20its%20headcount%20and%20any%20reported%20valuation&src=data-formd&kind=record&entity=Oncospace%2C%20Inc.&page=%2Fdata%2Fform-d%2Fcompany%2Foncospace-inc-1773640)

## The full lists

This record is a row of these lists. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, street, city, state, ZIP and 4 more), which open on your screen as soon as the payment clears and come by email.

- [Form D filings in Maryland](https://specstream.ai/data/form-d/state/maryland): 608 rows, by operating companies, filed since November 1, 2024, $30.40, or the new rows each week for $19 a month. Buy: https://specstream.ai/data/form-d/state/maryland
- [Form D filings in Biotechnology](https://specstream.ai/data/form-d/industry/biotechnology): 1,568 rows, by operating companies, filed since November 1, 2024, $78.40, or the new rows each week for $19 a month. Buy: https://specstream.ai/data/form-d/industry/biotechnology

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

## Company details from the filing

- Address: 1812 ASHLAND AVENUE, SUITE 100, Baltimore, MD, 21205
- Phone: (608) 239-6871
- Industry: Biotechnology
- Entity type: Corporation
- Incorporated in: Maryland
- Year incorporated: 2018
- Revenue range: No Revenues
- Exemptions claimed: Rule 506(b)
- SEC identifier (CIK): 1773640

## Form D filings

| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
| --- | --- | --- | --- | --- | --- | --- | --- |
| May 15, 2019 | Amendment | $1,500,000 | $900,000 | $600,000 | 11 | Mar 26, 2019 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1773640/000177364019000002/0001773640-19-000002-index.htm) |
| Apr 11, 2019 | New notice | $1,500,000 | $675,000 | $825,000 | 9 | Mar 26, 2019 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1773640/000177364019000001/0001773640-19-000001-index.htm) |

## Executive officers and directors named in the filing

| Name | Role | Note in the filing |
| --- | --- | --- |
| Praveen Sinha | Executive Officer, Director |  |
| Daniel Roche | Director |  |
| Todd McNutt | Executive Officer, Director |  |

## Other biotechnology companies in Maryland that filed recently

- [BlueHealer Inc.](https://specstream.ai/data/form-d/company/bluehealer-inc-2162934) $1 · Nov 4, 2026
- [Accufy Diagnostics, Inc.](https://specstream.ai/data/form-d/company/accufy-diagnostics-inc-2089723) $2 million · Oct 28, 2026
- [OS Therapies Inc](https://specstream.ai/data/form-d/company/os-therapies-inc-1795091) $7.2 million · Oct 23, 2026
- [Kaigene, Inc.](https://specstream.ai/data/form-d/company/kaigene-inc-1919055) $55 million · Oct 14, 2026
- [Templar Nova, Inc.](https://specstream.ai/data/form-d/company/templar-nova-inc-2158642) $7 million · Oct 7, 2026
- [Monocacy Therapeutics Inc.](https://specstream.ai/data/form-d/company/monocacy-therapeutics-inc-2137361) $25,000 · Oct 7, 2026
- [Seraxis Holdings, Inc.](https://specstream.ai/data/form-d/company/seraxis-holdings-inc-1845486) $10 million · Sep 24, 2026
- [Uvantis Therapeutics, Inc.](https://specstream.ai/data/form-d/company/uvantis-therapeutics-inc-2156954) $100,000 · Sep 23, 2026
- [Gliknik Inc](https://specstream.ai/data/form-d/company/gliknik-inc-1411569) $15 million · Sep 17, 2026
- [Georgiamune, Inc.](https://specstream.ai/data/form-d/company/georgiamune-inc-2148230) $92.7 million · Aug 17, 2026

[Every Form D from the week of May 13, 2019](https://specstream.ai/data/form-d/week/2019-05-13) · [All recent filings in Maryland](https://specstream.ai/data/form-d/state/maryland) · [All recent Biotechnology filings](https://specstream.ai/data/form-d/industry/biotechnology)

Read from SEC EDGAR. Amount sold is what Oncospace, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under [CC BY 4.0](https://creativecommons.org/licenses/by/4.0/).